1. Drew R.H., Gallis H.A. Azithromycin–spectrum of activity, pharmacokinetics and clinical application. Pharmacother. - 1992; 12:161-73.

2. Gordillo M.E., Singh K.V., Murray B.E. In vitro activity of azithromycin against bacterial enteric pathogens. Antimicrob Agents Chemother. - 1993; 37:1203.

3. Trautmann M., Riediger C., Moricke A., et al. Combined activity of azithromycin and lansoprazole against Helicobacter pylori. Helicobacter. - 1999; 4:113-20.

4. Stout J.E., Sens K., Mietzner S. Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing. Int J Antimicrob Agents 2005; 25:302-7.

5. Aydin D., Kucukbasmaci O., Gonullu N., Aktas Z. Susceptibilities of Neisseria gonorrhoeae and Ureaplasma urealyticum isolates from male patients with urethritis to several antibiotics including telithromycin. Chemotherapy. - 2005; 51:89-92.

6. Ohrt C., Willingmyre G.D., Lee P., et al. Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro. Antimicrob Agents Chemother 2002; 46:2518-24.

7. Cantin L., Chamberland S. In vitro evaluation of the activities of azithromycin alone and combined with pyrimethamine against Toxoplasma gondii. Antimicrob Agents Chemother. - 1993; 37:1993-6.

8. Mortensen J.E., Rodgers G.L. In vitro activity of gemifloxacin and other antimicrobial agents against isolates of Bordetella pertussis and Bordetella parapertussis. J Antimicrob Chemother 2000; 45(Suppl 1):47-9.

9. А.А. Мартинович и др. Азитромицин-сравнение качества инъекционных лекарственных форм оригинального препарата и его генериков., Клиничес. Микробиол. Антимикроб. Химиотерап., - 2011, т.13, № 4, - С. 335-336.

10. Азитан капсулы НД 42 Уз 6521-2017.